SEC Form 4 · accession 0001209191-15-021905
Larimar Therapeutics, Inc. · LRMR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alicia Secor
Officer — Chief Commercial Officer
Period of report
Feb 27, 2015
Accepted (ET)
Mar 3, 2015 · 9:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374690
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $38.65 | Feb 27, 2015 | A | 60,000 | A | — | Feb 27, 2025 | Common Stock | 60,000 | 219,235 | D |
Explanation of responses
- F125% of this option vests on February 27, 2016, and the remainder vests in equal monthly installments thereafter over 36 months.